Pharmaceutical Rapid Microbiology Testing Market

Market Insights

Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Rapid microbiology testing provides qualitative, quantitative, and identification results. The demand for rapid microbiological tests in the pharmaceutical industry is expected to increase significantly in the next few years in emerging economies such as China and India.

The technology types studied for analyzing the overall rapid microbiology tests in the pharmaceutical industry are immunology-based methods, nucleic acid amplification tests, mass spectrometry-based methods, flow cytometry-based methods, growth-based detection technologies, and biochemical tests. This report also highlights information about the application segment in the pharmaceutical industry, such as raw material testing, in-process testing, microbial limit testing, bioburden assessment, process water testing, environmental monitoring, and sterility testing. The market size and forecast for each of these segments for 2014–2022 are provided in this study, along with respective CAGRs for the forecast period 2016–2022.

Geographically, the rapid microbiology testing pharmaceutical market is studied for the following regional markets:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Russia
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2014–2022. Market growth rates for the forecast period 2016–2022 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global rapid microbiology testing industry.

Tools such as market positioning of key players and attractive investment propositions provide the readers with insights into the competitive scenario of the global fast microbiology testing industry in the pharmaceutical industry. This report concludes with a company profiles section that highlights important information about the key players engaged in rapid microbiology testing in the pharmaceutical industry.

Based on the application, the global market for rapid microbiology tests in the pharmaceutical industry is segmented as follows:

• Raw material testing
• In-process testing
• Microbial limit testing
• Bioburden assessment
• Process water testing
• Environmental monitoring
• Sterility testing

Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in pharmaceutical industry settings. The applications in the global market for rapid microbiology tests in the pharmaceutical industry are segmented into raw material testing, in-process testing, microbial limit testing, bioburden assessment, process water testing, environmental monitoring, and sterility testing. The sterility testing application held the largest share in the global rapid microbiology tests in the pharmaceutical market due to its wide application in the final drug product and other applications.Process water testing is anticipated to witness the highest growth in the global market for rapid microbiological tests in the pharmaceutical industry.

Based on the type of technology, the global market for rapid microbiology tests in the pharmaceutical industry is segmented as follows:

• Immunology based methods
• Nucleic acid-based amplification tests
• polymerase chain reaction
• Nucleic acid sequence-based amplification (NASBA)
• Others
• Mass spectrometry-based methods
• Flow cytometry-based methods
• Growth-based detection technologies
• ATP-bioluminescence
• Colorimeter detection
• Autofluorescence detection
• Biochemical Tests

Rapid microbiology tests, also known as alternative microbiological methods, are the technologies that allow the user to get microbiology test results faster compared to the traditional culture-plate methods. Conventional microbial analyses require extensive manual operations. In addition, the necessity for visual determination of the growth of microbial colonies leads to longer assay times. Rapid microbial tests provide faster results, but the key to acceptance is staying consistent with the compendial method. The rapid microbiology tests have been broadly segmented into immunology-based methods, nucleic acid amplification tests, mass spectrometry-based methods, flow cytometry-based methods, growth-based detection technologies, and biochemical tests.

The nucleic acid amplification tests are further segmented into a polymerase chain reaction, nucleic acid sequence-based amplification, and others. Growth-based detection technologies are further classified into ATP-bioluminescence, colorimeter detection, and autofluorescence detection. Nucleic acid amplification test-based methods held the largest share in the rapid microbiology market due to their wide application in the pharmaceutical industry. Moreover, low cost and high speed would further fuel the market growth of immunology-based methods.

For the purpose of this study, the global market for rapid microbiology tests in the pharmaceutical industry is classified as follows:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa

The geographical segmentation of the global rapid microbiology tests market comprises North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In 2015, North America accounted for the largest market in the rapid microbiology tests market due to the presence of major life science companies in the region. Moreover, in North America, enhanced government initiatives to regulate rapid microbiological testing in the industrial setting, especially in the pharmaceutical segment, have further assisted the growth of the primary microbiology testing market in the region. Asia Pacific is expected to grow at the highest rate during the forecast period due to the population growth in the region and increasing awareness regarding product safety. Rising investments by the major life science companies in the region would further fuel the growth of rapid microbiology tests in the pharmaceutical market in the area.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global Rapid Microbiology Tests in Pharmaceutical Market Portaiture
2.2 Global Rapid Microbiology Tests in Pharmaceutical Market, by Technology, 2015 (USD Mn)
2.4 Rapid Microbiology Tests in Pharmaceutical Market Share, by Geography, 2015 (Value %)

Chapter 3 Rapid Microbiology Tests in Pharmaceutical Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Rapid Microbiology Tests: Future Trends and Applications
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.2 Rising Patient Awareness
3.3.1.3 Rising public awareness related to early diagnosis of infectious diseases
3.3.2 Challenges
3.3.2.1 Level of Accuracy of rapid microbiology technques compared to traditional methods
3.3.3 Opportunities
3.3.3.1 Technological Advancements
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis By Key Players, 2015 (Value %)

Chapter 4 Global Rapid Microbiology Tests in Pharmaceutical Market, by Technology
4.1 Preface
4.2 Immunology based Methods
4.3 Nucleic acid based amplification tests
4.3.1 Polymerase Chain Reaction
4.3.2 Nucleic Acid Sequence-based amplification (NASBA)
4.3.3 Others
4.4 Mass Spectrometry based Methods
4.5 Flow Cytometry based Methods
4.6 Growth-based detection technologies
4.6.1 ATP-bioluminescence
4.6.2 Colorimeter detection
4.6.3 Autofluorescence detection
4.7 Biochemical Tests

Chapter 5 Global Rapid Microbiology Tests in Pharmaceutical Market, by Application
5.1 Preface
5.2 Raw material testing
5.3 In-process testing
5.4 Microbial limit testing
5.5 Bioburden assessment
5.6 Process water testing
5.7 Environmental monitoring
5.8 Sterility testing

Chapter 6 Global Rapid Microbiology Tests in Pharmaceutical Market, By Geography
6.1 Overview
6.2 North America
4.2.2. U.S.
4.2.1. Canada
6.3 Europe
4.2.2. U.K.
4.2.1. Germany
4.2.2. Rest of Europe
6.4 Asia Pacific
4.2.2. Japan
4.2.1. China
4.2.2. Rest of Asia Pacific
6.4 Latin America
6.5 Middle East and Africa

Chapter 7 Company Profiles
7.1 Abbott Laboratories, Inc.
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Portfolio
7.1.4 News Coverage
7.2 Alere, Inc.
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Portfolio
7.2.4 News Coverage
7.3 Bio-Rad Laboratories
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Portfolio
7.3.4 News Coverage
7.4 Danaher Corporation
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Portfolio
7.4.4 News Coverage
7.5 Becton, Dickinson And Company
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Portfolio
7.5.4 News Coverage
7.6 Gen-Probe, Inc.
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product portfolio
7.6.4 News Coverage
7.7 F. Hoffman-La Roche AG
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Portfolio
7.7.4 News Coverage
7.8 Orasure Technologies, Inc.
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Portfolio
7.8.4 News Coverage
7.9 Siemens Healthcare
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Portfolio
7.9.4 News Coverage
7.10 Thermo Fisher Scientific, Inc.
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Portfolio
7.8.4 News Coverage
7.11 Sysmex Corporation
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Portfolio
7.9.4 News Coverage
7.10 Other Notable Market Players

List of Figures

FIG. 1 Global Rapid Microbiology Tests Pharmaceutical Market, by Technology, 2015 (USD Mn)
FIG. 2 Relativity Analysis: Rapid Microbiology Tests Pharmaceutical Market, by Application, 2015 & 2022 (USD Mn)
FIG. 3 Global Rapid Microbiology Tests Pharmaceutical Market Share, by Geography, 2015 (Value %)
FIG. 4 Attractive Investment Proposition, Global Rapid Microbiology Tests Pharmaceutical Market, 2015
FIG. 5 Market Share Analysis By Key Players, 2015 (Value %)
FIG. 6 Global Immunology based Methods Market Revenue, 2013 – 2022 (USD Mn)
FIG. 7 Global Polymerase Chain Reaction Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Nucleic Acid Sequence-based amplification (NASBA) Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Others Market Revenue, 2013 – 2022 (USD Mn)
FIG. 10 Global Mass Spectrometry based Methods Market Revenue, 2013 – 2022 (USD Mn)
FIG. 11 Global Flow Cytometry based Methods Revenue,, 2013 – 2022 (USD Mn)
FIG. 12 Global ATP-bioluminescence Revenue, 2013 – 2022 (USD Mn)
FIG. 13 Global Colorimeter detection Market Revenue, 2013 – 2022 (USD Mn)
FIG. 14 Global Autofluorescence detection Market Revenue, 2013 – 2022 (USD Mn)
FIG. 15 Global Biochemical Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 16 Global Raw material testing Segment, 2013 – 2022 (USD Mn)
FIG. 17 Global In-process testing Segment, 2013 – 2022 (USD Mn)
FIG. 17 Global Microbial limit testing Segment, 2013 – 2022 (USD Mn)
FIG. 15 Global Bioburden assessment Segment, 2013 – 2022 (USD Mn)
FIG. 16 Global Process water testing Segment, 2013 – 2022 (USD Mn)
FIG. 17 Global Environmental monitoring Segment, 2013 – 2022 (USD Mn)
FIG. 17 Global Sterility testing Segment, 2013 – 2022 (USD Mn)
FIG. 18 Global U.S. Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)
FIG. 19 Global Canada Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)
FIG. 20 Global U.K. Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)
FIG. 21 Global Germany Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)
FIG. 22 Global Rest of Europe Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)
FIG. 23 Global China Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)
FIG. 24 Global Japan Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)
FIG. 25 Global Rest of Asia Pacific Rapid Microbiology Tests Pharmaceutical Market, 2013 – 2022 (USD Mn)

List of Tables

TABLE 1 Global Rapid Microbiology Tests Pharmaceutical Market Revenue, by Technology Type, 2013 – 2022 (USD Mn)
TABLE 2 Global Rapid Microbiology Tests Pharmaceutical Market Revenue, by Application, 2013 – 2022 (USD Mn)
TABLE 3 Global Rapid Microbiology Tests Pharmaceutical Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 4 North America Rapid Microbiology Tests Pharmaceutical Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 5 Europe Rapid Microbiology Tests Pharmaceutical Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Asia – Pacific Rapid Microbiology Tests Pharmaceutical Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Latin America Rapid Microbiology Tests Pharmaceutical Market Revenue, by Regions, 2013 – 2022 (USD Mn)
TABLE 8 Middle East and Africa Rapid Microbiology Tests Pharmaceutical Market Revenue, by Regions, 2013 – 2022 (USD Mn)